Darunavir Glenmark

Darunavir Glenmark is an antiretroviral medication used to manage HIV infection. This oral medication is manufactured by Glenmark Arzneimittel Gmbh and is part of a comprehensive treatment regimen.

Darunavir Glenmark is primarily used in the treatment of HIV infection. It works by inhibiting the protease enzyme, which is essential for the virus to replicate. This medication is often combined with other antiretroviral drugs to effectively manage HIV and improve patient outcomes. Darunavir is used for what is commonly referred to as highly active antiretroviral therapy (HAART).

Common effects of Darunavir Glenmark may include nausea, diarrhea, and headache. Some individuals might experience rash or changes in liver function tests. It is important to monitor for any adverse reactions and consult a healthcare provider if they persist or worsen.

Darunavir Glenmark should be used with caution in patients with liver disease or a history of liver problems. It is important to follow the prescribed dosage and administration instructions. Patients should avoid grapefruit and grapefruit juice, as they can affect the medication's effectiveness.

Darunavir Glenmark can interact with various medications, including other antiretrovirals, antifungals, and certain antibiotics. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain CYP inhibitors may also affect the metabolism of Darunavir.